Concor COR 2.5

Overview Authored by Reviewed by References

Overview

Medicine composition:
Bisoprolol

Marketed by:
Merck Specialities Pvt. Ltd.

Manufactured By :
Merck Specialities Pvt. Ltd.

Medicine Type :
Allopathy

Prescription Type :
Prescription Required

Approval :
DCGI (Drugs Controller General of India)

Pharmacological Class :

Beta-Blocker,

Schedule :
Schedule H

References

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/019982s014lbl.pdf

https://www.medicines.org.uk/emc/product/6126/pil#gref

https://go.drugbank.com/drugs/DB00612

Leopold G. Balanced pharmacokinetics and metabolism of bisoprolol. Journal of cardiovascular pharmacology. 1986 Jan 1;8:S16-20.

Willenheimer, R., van Veldhuisen, et.al. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. Circulation, 2005 112(16), pp.2426-2435.

Authored by

Dr. Mahalakshmi Sivashankaran

Dr. Mahalakshmi Sivashankaran joined Medical Dialogues as an Intern in 2023. She is a BDS graduate from Manipal College of Dental Sciences, Mangalore Batch 2022, and worked as a Junior Resident at VMMC & Safdarjung Hospital at the Department of Dental Surgery till January 2023. She has completed a Diploma in Executive Healthcare management from the Loyola Institute of Business Administration, developing skills in Healthcare Management and Administration. She covers several medical specialties including Dental, ENT, Diagnostics, Pharmacology, Neurology, and Cardiology.

Reviewed by

Dr JUHI SINGLA

Dr JUHI SINGLA has completed her MBBS from Era’s Lucknow Medical college and done MD pharmacology from SGT UNIVERSITY Gurgaon. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Page Created On: 3 May 2023 10:00 AM GMT

Page Last Updated On: 2023-05-05 06:33:30.0